Biologics

Randal "Randy" Mills, PhD, co-founder of Aziyo Biologics, assumed the role of president and CEO of the company.

Orthofix and CGBio partnered for the development and commercialization of Novosis, a bone growth material and regenerative products.

AlloSource's president and CEO, Tom Cycyota, plans to retire after leading the biologics company for 22 years.

Anika Therapeutics earned the American Orthopedic Society for Sports Medicine's ACE award for cutting-edge innovation for its Tactoset product.

Five orthopedic surgeons are part of a new regenerative medicine scientific advisory board for Mimedx.

Orthofix's Virtuos Lyograft allograft was debuted by neurosurgeon Thomas Ellis, MD.

NovaBone, a biologic medtech company focused on orthopedic and dental products, hired Brian Carlisle as CEO.

From a notable stem cell study to newly launched products, here are eight updates in regenerative orthopedic medicine:

Ossifix Orthopedics will launch its demineralized bone matrix, made from 100 percent human bone tissue in August.

The Pediatric Orthopedic Center in Cedar Knolls, N.J., became the first pediatric-only orthopedic practice in its region to add the Bear implant for ACL restoration.